FDA ’s ‘Bad Ad’ Program Encourages HCPs to Report False or Misleading Prescription Drug Promotion
FDA ’s ‘Bad Ad’ Program Encourages HCPs to Report False or Misleading Prescription Drug Promotion
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Drugs & Pharmacology